Search

everythinglearnresearchcommunity

for

Search:↓

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

More research is needed before recommending photobiomodulation devices for hair loss treatment.

Early recognition of methotrexate toxicity symptoms is crucial.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Photobiomodulation is safe and effective for treating certain conditions like nerve pain and hair loss.

Botryococcus terribilis and its compounds may promote hair growth and improve hair health.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

A new method to make Finasteride is more cost-effective and yields 16%.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

The combined therapy significantly increased hair density and was safe for treating hair loss.

New mutations in MBTPS2 reduce its function and cause IFAP syndrome with unusual symptoms.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Porphyria cutanea tarda causes skin issues due to an enzyme deficiency.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

Certain polyphenols may help treat skin pigmentation disorders.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Combined light therapy improves eye health and quality of life for those with meibomian gland dysfunction.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

PHGDH promotes cancer growth by aiding cell proliferation and tumor progression.

Enzymatic phosphorylation of hair keratin improves the effectiveness of hair products with cationic ingredients.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

MPA increases cancer spread by boosting Eph A2 activity.

Triamcinolone is more effective and safer for treating feline pemphigus foliaceus than prednisone.

Propylthiouracil treatment can cause hair loss.

ALRN-6924 may prevent hair loss caused by chemotherapy.